Evolution of Patient Concerns Regarding Safety of Gene Therapy Products in the Hemophilia Community

Time: 10:00 am
day: Day One


  • The tainted blood crisis had a long-term effect on patient concerns about product safety
  • This effect carries over into concerns regarding gene transfer and other newer technologies
  • Adequately addressing these concerns is critical to patient acceptance and adoption of these therapies